Long-term oral administration of probucol (4,4'-(isopropylidenedithio) bis(2,6-di-t-butylphenol)) (DH-581) in the management of hypercholesterolemia.
D000284:Administration, Oral; D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004586:Electrophoresis; D005141:Eyelid Diseases / Q000188:drug therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage*; D010641:Phenotype; D011341:Probucol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D010636:Phenols; D014280:Triglycerides; D011341:Probucol